Panbela Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -8,103 | -6,726 | -7,047 |
EBITDA | -7,080 | -7,195 | -6,421 |
EBIT | -8,103 | -7,238 | -6,464 |
Net Income | -7,139 | -7,120 | -6,474 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -981 | -9,392 | -3,080 |
Cash | 59 | 262 | 2,578 |
Basic Shares | 4,854 | 3,125 | 237,234 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-1,638 | $0 | $0 |
Gross Profit | -25,647 | -35,731 | -10,010 | -5,754 |
EBITDA | -51,294 | -34,761 | -10,611 | -5,149 |
EBIT | -51,461 | -34,777 | -10,621 | -5,154 |
Net Income | -25,263 | -34,933 | -10,135 | -4,768 |
Net Change In Cash | 0 | -1,638 | 0 | 0 |
Free Cash Flow | -25,249 | -15,936 | -6,704 | -3,854 |
Cash | 2,578 | 1,285 | 11,867 | 9,022 |
Basic Shares |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.47 |
2024-03-31 | -$2.28 |
2023-12-31 | -$65.90 |
2023-09-30 | -$2.69 |
